{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T15:18:15Z","timestamp":1760368695569},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2007,6,1]],"date-time":"2007-06-01T00:00:00Z","timestamp":1180656000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Urologe"],"published-print":{"date-parts":[[2007,6]]},"DOI":"10.1007\/s00120-007-1341-6","type":"journal-article","created":{"date-parts":[[2007,4,25]],"date-time":"2007-04-25T06:02:24Z","timestamp":1177480944000},"page":"622-627","source":"Crossref","is-referenced-by-count":1,"title":["Statine und Probiotika in der Pr\u00e4vention urologischer Erkrankungen"],"prefix":"10.1007","volume":"46","author":[{"given":"C.","family":"Fischer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Altwein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"1341_CR1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF00446731","volume":"141","author":"Allison","year":"1985","unstructured":"Allison MJ, Dawson KA, Mayberry WR et al. (1985) Oxalobacter formigenes gen. nov., sp. nov.: oxalate-degrading anaerobes that inhabit the gastrointestinal tract. Arch Microbiol 141: 1\u20137","journal-title":"Arch Microbiol"},{"key":"1341_CR2","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1159\/000282409","volume":"49","author":"Aso","year":"1992","unstructured":"Aso Y and Akaza H (1992) Prophylactic effect of a Lactobacillus casei preparation on the recurrence of superficial bladder cancer. BLP Study Group. Urol Int 49: 125\u2013129","journal-title":"Urol Int"},{"key":"1341_CR3","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1159\/000475138","volume":"27","author":"Aso","year":"1995","unstructured":"Aso Y, Akaza H, Kotake T et al. (1995) Preventive effect of a Lactobacillus caseipreparation on the recurrence of superficial bladder cancer in a double-blind trial. The BLP Study Group. Eur Urol 27: 104\u2013109","journal-title":"Eur Urol"},{"key":"1341_CR4","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1001\/archinte.160.15.2363","volume":"160","author":"Blais","year":"2000","unstructured":"Blais L, Desgagne A, LeLorier J (2000) 3-Hydroxy-3-methylglutarylcoenzyme A reductase inhibitors and the risk of cancer: a nested case-control study. Arch Intern Med 160: 2363\u20132368","journal-title":"Arch Intern Med"},{"key":"1341_CR5","first-page":"973","volume":"108","author":"Bruce","year":"1973","unstructured":"Bruce AW, Chadwick P, Hassan A, et al. (1973) Recurrent urethritis in women. Can Med Assoc J 108: 973\u2013976","journal-title":"Can Med Assoc J"},{"key":"1341_CR6","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1097\/00001648-200205000-00005","volume":"13","author":"Coogan","year":"2002","unstructured":"Coogan PF, Rosenberg L, Palmer JR et al. (2002) Statin use and the risk of breast and prostate cancer. Epidemiology 13: 262\u2013267","journal-title":"Epidemiology"},{"key":"1341_CR7","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1097\/01.ju.0000158044.94188.88","volume":"173","author":"Cyrus-David","year":"2005","unstructured":"Cyrus-David MS, Weinberg A, Thompson T et al. (2005) The effect of statins on serum prostate specific antigen levels in a cohort of airline pilots: a preliminary report. J Urol 173: 1923\u20131925","journal-title":"J Urol"},{"key":"1341_CR8","doi-asserted-by":"crossref","first-page":"3841","DOI":"10.1128\/AEM.68.8.3841-3847.2002","volume":"68","author":"Duncan","year":"2002","unstructured":"Duncan SH, Richardson AJ, Kaul P et al. (2002) Oxalobacter formigenses and ist potential role in human health. Appl Environ Microbiol 68: 3841\u20133847","journal-title":"Appl Environ Microbiol"},{"key":"1341_CR9","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1086\/497832","volume":"41","author":"Enache-Angoulvant","year":"2005","unstructured":"Enache-Angoulvant A and Hennequin C (2005) Invasive Saccharomyces infection: a comprehensive review. Clin Infect Dis 41:1559\u20131568","journal-title":"Clin Infect Dis"},{"key":"1341_CR10","unstructured":"Food and Agriculture Organization of the United Nations and World Health Organization (2002) Guidelines for the evaluation of probiotics in food. WHO, Genf http:\/\/www.who.int\/foodsafety\/fs_management\/en\/probiotic_guidelines.pdf"},{"key":"1341_CR11","first-page":"92","volume":"9","author":"Gardiner","year":"2002","unstructured":"Gardiner GE, Heinemann C, Bruce AW et al. (2002) Persistence of Lactobacillus fermentum RC-14 and Lactobacillus rhamnosus GR-1 but not L. rhamnosus GG in the human vagina as demonstrated by randomly amplified polymorphic DNA. Clin Diagn Lab Immunol 9: 92\u201396","journal-title":"Clin Diagn Lab Immunol"},{"key":"1341_CR12","doi-asserted-by":"crossref","first-page":"4120","DOI":"10.1038\/sj.onc.1202792","volume":"18","author":"Ghosh","year":"1999","unstructured":"Ghosh PM, Ghosh-Choudhury N, Moyer ML et al. (1999) Role of RhoA-activation in the growth and morphology of a murine prostate tumor cell line. Oncogene 18: 4120\u20134130","journal-title":"Oncogene"},{"key":"1341_CR13","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1200\/JCO.2004.02.027","volume":"22","author":"Graaf","year":"2004","unstructured":"Graaf MR, Beiderbeck AB, Egberts ACG et al. (2004) The risk of cancer in users of statins. J Clin Oncol 22: 2388\u20132394","journal-title":"J Clin Oncol"},{"key":"1341_CR14","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1097\/00005176-200001000-00018","volume":"30","author":"Guandalini","year":"2000","unstructured":"Guandalini S, Pensabene L, Zikri MA et al. (2000) Lactobacillus GG administered in oral rehydration solution to children with acute diarrhea: a multicenter European trial. J Pediatr Gastroenterol Nutr 30: 54\u201360","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"1341_CR15","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.eururo.2004.09.011","volume":"47","author":"Hoesl","year":"2005","unstructured":"Hoesl CE and Altwein JE (2005) The probiotic approach: an alternative treatment option in urology. Eur Urol 47: 288\u2013296","journal-title":"Eur Urol"},{"key":"1341_CR16","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S1201-9712(99)90024-3","volume":"3","author":"Hoyos","year":"1999","unstructured":"Hoyos AB (1999) Reduced incidence of necrotizing enterocolitis associated with enteral administration of Lactobacillus acidophilus and Bifidobacterium infantis to neonates in an intensive care unit. Int J Infect Dis 3: 197\u2013202","journal-title":"Int J Infect Dis"},{"key":"1341_CR17","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0192-0561(98)00072-1","volume":"21","author":"Kato","year":"1999","unstructured":"Kato I, Tanaka K, Yokokura T (1999) Lactic acid bacterium potently induces the production of interleukin-12 and interferon-\u03b1 by mouse splenocytes. Int J Immunopharmacol 21: 121\u2013131","journal-title":"Int J Immunopharmacol"},{"key":"1341_CR18","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/sj.bjc.6601566","volume":"90","author":"Kaye","year":"2004","unstructured":"Kaye JA and Jick H (2004) Statin use and cancer risk in the General Practice Research Database. Br J Cancer 90: 635\u2013637","journal-title":"Br J Cancer"},{"key":"1341_CR19","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1349-7006.2002.tb01198.x","volume":"93","author":"Lim","year":"2002","unstructured":"Lim BK, Mahendran R, Lee YK et al. (2002) Chemopreventive effect of Lactobacillus rhamnosus on growth of a subcutaneously implanted bladder cancer cell line in the mouse. Jpn J Cancer Res 93: 36\u201341","journal-title":"Jpn J Cancer Res"},{"key":"1341_CR20","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/j.1469-0691.1999.tb00144.x","volume":"5","author":"Mackay","year":"1999","unstructured":"Mackay AD, Taylor MB, Kibbler CC et al. (1999) Lactobacillus-endocarditis caused by a probiotic organism. Clin Microbiol Infect 5: 290\u2013292","journal-title":"Clin Microbiol Infect"},{"key":"1341_CR21","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1046\/j.1440-1711.2000.00887.x","volume":"78","author":"Matsuzaki","year":"2000","unstructured":"Matsuzaki T, Chin J (2000) Modulating immune responses with probiotic bacteria. Immunol Cell Biol 78: 67\u201373","journal-title":"Immunol Cell Biol"},{"key":"1341_CR22","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1016\/j.urology.2005.08.053","volume":"66","author":"Moyad","year":"2005","unstructured":"Moyad MA, Merrick GS, Butler WM et al. (2005) Statins, especially atorvastin, may favorably influence clinical presentation and biochemical progression-free survival after brachytherapy for clinically localized prostate cancer. Urology 66: 1150\u20131154","journal-title":"Urology"},{"key":"1341_CR23","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.ucl.2004.03.003","volume":"31","author":"Moyad","year":"2004","unstructured":"Moyad, MA. and Sonnleithner, M. (2004) Prostate cancer and coronary heart disease: correlation or coincidence? Urol Clin North Am 31: 207","journal-title":"Urol Clin North Am"},{"key":"1341_CR24","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/S0140-6736(01)53633-8","volume":"186","author":"Newman","year":"1915","unstructured":"Newman D (1915) The treatment of cystitis by intravesical injections of lactic bacillus cultures. Lancet 186: 330\u2013332","journal-title":"Lancet"},{"key":"1341_CR25","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1093\/jnci\/92.8.613","volume":"92","author":"Newschaffer","year":"2000","unstructured":"Newschaffer CJ, Otani K, McDonald MK et al. (2000) Causes of death in elderly prostate cancer patients and in a comparison nonprostate cancer cohort. J Natl Cancer Inst 92: 613\u2013621","journal-title":"J Natl Cancer Inst"},{"key":"1341_CR26","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1159\/000058450","volume":"68","author":"Ohashi","year":"2002","unstructured":"Ohashi Y, Nakai S, Tsukamoto T et al. (2002) Habitual intake of lactic acid bacteria and risk reduction of bladder cancer. Urol Int 68: 273\u2013280","journal-title":"Urol Int"},{"key":"1341_CR27","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0002-9149(00)00910-3","volume":"86","author":"Pedersen","year":"2000","unstructured":"Pedersen TR, Wilhelmsen L, Faergeman O et al. (2000) Follow-up study of patients randomized in the Scandinavian Simvastatin Survival Study (4S) of cholesterol lowering. Am J Cardiol 86: 257\u2013262","journal-title":"Am J Cardiol"},{"key":"1341_CR28","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0002-9270(99)00809-6","volume":"95","author":"Pochapin","year":"2000","unstructured":"Pochapin M (2000) The effect of probiotics on Clostridium difficile diarrhea. Am J Gastroenterol 95(Suppl 1): 11\u201313","journal-title":"Am J Gastroenterol"},{"key":"1341_CR29","first-page":"2184","volume":"352","author":"Poynter","year":"2005","unstructured":"Poynter JN, Gruber StB, Higgins PDR et al. (2005) Statins and the risk of colorectal cancer NEJM 352: 2184\u20132192","journal-title":"Statins and the risk of colorectal cancer NEJM"},{"key":"1341_CR30","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1086\/514766","volume":"28","author":"Rautio","year":"1999","unstructured":"Rautio M, Jousimies-Somer H, Kauma H et al. (1999) Liver abscess due to a Lactobacillus rhamnosus strain indistinguishable from L. rhamnosus strain GG. Clin Infect Dis 28: 159\u2013160","journal-title":"Clin Infect Dis"},{"key":"1341_CR31","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1093\/aje\/kwi203","volume":"162","author":"Shannon","year":"2005","unstructured":"Shannon J, Tewoderos S, Garzotto M et al. (2005) Statins and prostate cancer risk: a case-control study. Am J Epidemiol 162: 318\u2013325","journal-title":"Am J Epidemiol"},{"key":"1341_CR32","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1016\/S0022-5347(05)65817-X","volume":"166","author":"Sidhu","year":"2001","unstructured":"Sidhu H, Allison MJ, Chow JM et al. (2001) Rapid reversal of hyperoxaluria in a rat model after probiotic administration of Oxalobacter formigenes. J Urol 166: 1487\u20131491","journal-title":"J Urol"},{"key":"1341_CR33","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/S0140-6736(04)16936-5","volume":"364","author":"Strandberg","year":"2004","unstructured":"Strandberg TE, Pyorala K, Cook TJ et al. (2004) Mortality and incidence of cancer during 10-year follow-up of the Scandinavian Simvastatin Survival Study (4S). Lancet 364: 771\u2013777","journal-title":"Lancet"},{"key":"1341_CR34","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1016\/S0022-5347(05)65625-X","volume":"166","author":"Takahashi","year":"2001","unstructured":"Takahashi T, Kushiro A, Nomoto K et al. (2001) Antitumor effects of the intravesical instillation of heat killed cells of the Lactobacillus casei strain Shirota on the murine orthotopic bladder tumor MBT-2. J Urol 166: 2506\u20132511","journal-title":"J Urol"},{"key":"1341_CR35","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1079\/NRR200377","volume":"17","author":"Van","year":"2004","unstructured":"Van LJ, Collins K (2004) Synbiotics suppress parameters of carcinogenesis in human volunteers: the SYNCAN project. ORAFTI Research Conference. Nutr Res Rev 17: 89\u201398","journal-title":"Nutr Res Rev"},{"key":"1341_CR36","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1089\/089277903322145431","volume":"17","author":"Watterson","year":"2003","unstructured":"Watterson JD, Cadieux PA, Beiko DT et al. (2003) Oxalate-degrading enzymes from Oxalobacter formigenes: a novel device coating to reduce urinary tract biomaterial-related encrustation. J Endourol 17: 269\u2013274","journal-title":"J Endourol"},{"key":"1341_CR37","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1038\/sj.pcan.4500834","volume":"8","author":"Wuermli","year":"2005","unstructured":"Wuermli L, Joerger M, Henz S et al. (2005) Hypertriglyceridemia as a possible risk factor for prostate cancer. Prostate Cancer Prostatic Dis 8: 316\u2013320","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"1341_CR38","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1155\/2004\/417653","volume":"18","author":"Yesovitch","year":"2004","unstructured":"Yesovitch R, Cohen A, Szilagyi A (2004) Failure to improve parameters of lactose maldigestion using the multiprobiotic product VSL3 in lactose maldigesters: a pilot study. Can J Gastroenterol 18: 83\u201386","journal-title":"Can J Gastroenterol"}],"container-title":["Der Urologe"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00120-007-1341-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00120-007-1341-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00120-007-1341-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T10:58:44Z","timestamp":1558609124000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00120-007-1341-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,6]]},"references-count":38,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2007,6]]}},"alternative-id":["1341"],"URL":"https:\/\/doi.org\/10.1007\/s00120-007-1341-6","relation":{},"ISSN":["0340-2592","1433-0563"],"issn-type":[{"value":"0340-2592","type":"print"},{"value":"1433-0563","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,6]]}}}